130 related articles for article (PubMed ID: 38872933)
1. The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones.
Li M; Chang Q; Luo Y; Pan J; Hu Y; Liu B; Ma M; Wang Q; Guo Y; Wang Q
Front Cell Dev Biol; 2024; 12():1384233. PubMed ID: 38872933
[No Abstract] [Full Text] [Related]
2. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
3. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
[TBL] [Abstract][Full Text] [Related]
4. Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole.
Li Y; Zhu Y; Li D; Liu W; Zhang Y; Liu W; Zhang C; Tao T
Front Endocrinol (Lausanne); 2023; 14():1265152. PubMed ID: 37929036
[TBL] [Abstract][Full Text] [Related]
5. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
7. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
8. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
9. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
[TBL] [Abstract][Full Text] [Related]
10. Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome.
Ge J; Yang N; Zhang X; Li M; Zhang W; He J; Zhu H; Cheng X; Shen S; Ge W
Reprod Sci; 2022 Dec; 29(12):3449-3458. PubMed ID: 35835901
[TBL] [Abstract][Full Text] [Related]
11.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
12. Probiotic
Zhang J; Sun Z; Jiang S; Bai X; Ma C; Peng Q; Chen K; Chang H; Fang T; Zhang H
mSystems; 2019; 4(2):. PubMed ID: 31020040
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.
Qi X; Yun C; Sun L; Xia J; Wu Q; Wang Y; Wang L; Zhang Y; Liang X; Wang L; Gonzalez FJ; Patterson AD; Liu H; Mu L; Zhou Z; Zhao Y; Li R; Liu P; Zhong C; Pang Y; Jiang C; Qiao J
Nat Med; 2019 Aug; 25(8):1225-1233. PubMed ID: 31332392
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Serum Visfatin Level in Non-obese Women with Polycystic Ovary Syndrome and Matched Control.
Ali AI; Nori W
Reprod Sci; 2022 Nov; 29(11):3285-3293. PubMed ID: 35687303
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
[TBL] [Abstract][Full Text] [Related]
17. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
[TBL] [Abstract][Full Text] [Related]
20. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
